Atlas Trials

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

Clinical trial NCT06360744 · COMPLETED

Trial details

NCT number
NCT06360744
Sponsor
Jens D Lundgren, MD
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SARS CoV 2 Infection
Start date
2021-07-05
Primary completion
2023-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.